⚠️ JAMA Study (July 2024): 700% Increased NAION Risk
GLP-1 Vision Loss Calculator
Estimate your Ozempic/Wegovy NAION compensation
Total blindness in one eye from NAION
$
Advertisement
GLP-1 Vision Loss FAQ
What is NAION?
NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) is a condition where blood flow to the optic nerve is blocked, causing sudden vision loss. A July 2024 JAMA study found GLP-1 users have 700% higher risk.
Which GLP-1 drugs are linked to vision loss?
Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, and Saxenda have all been linked to increased NAION risk in studies. All contain semaglutide or tirzepatide.
Based on official MDL 3097 (E.D. Pennsylvania) litigation benchmarks, peer-reviewed JAMA Ophthalmology clinical studies, and FDA safety signals.